ArticleBlood2016
Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.
Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 105 citations in OpenAlex.
- Genome-wide association analyses identified novel susceptibility loci for pulmonary embolism among Han Chinese population.BMC medicine · 2023Pooled it
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.Blood advances · 2018Guideline
- Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.BMJ (Clinical research ed.) · 2017Pooled it
- Anticoagulant protein activity value thresholds for the occurrence of venous thromboembolism in pregnant women with thrombophilia.International journal of hematology · 2026Article
- Carrier screening in the reproductive setting-Are there medical implications for the heterozygote?-A guide for clinicians.Pregnancy (Hoboken, N.J.) · 2026Review
- Recommendations from guidelines for the prevention of venous thromboembolism in pregnant women with inherited thrombophilia.Archives of gynecology and obstetrics · 2026Review
- A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan.Thrombosis journal · 2026Article
- Antepartum and Postpartum Thromboprophylaxis Preferences: Insights From a Single-Center Survey.Health science reports · 2026Article
- Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum.MedComm · 2024Article
- To Test or Not to Test: Routine Thrombophilia Diagnostic Screening of Women with Reproductive Failures.Journal of clinical medicine · 2023Article
- Evaluation of Low-Molecular-Weight Heparin Treatment on First- and Second-Trimester Screening Test Results.Cureus · 2023Article
- The Proper Diagnosis of Thrombophilic Status in Preventing Fetal Growth Restriction.Diagnostics (Basel, Switzerland) · 2023Review
- A Retrospective Assessment of Thrombophilia in Pregnant Women with First and Second Trimester Pregnancy Loss.International journal of environmental research and public health · 2022Observational
- Venous Thromboembolism During Pregnancy and the Postpartum Period: Risk Factors, Diagnostic Testing, and Treatment.Obstetrical & gynecological survey · 2022Review
- Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol.International journal of hematology · 2022Article
- Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy.Breathe (Sheffield, England) · 2022Review
- Association Between Maternal Weight Gain in Different Periods of Pregnancy and the Risk of Venous Thromboembolism: A Retrospective Case-Control Study.Frontiers in endocrinology · 2022Article
- Prevention of Venous Thromboembolism in 2020 and Beyond.Journal of clinical medicine · 2020Review
- VTE risk assessment in pregnancy.Research and practice in thrombosis and haemostasis · 2020Article
- A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients.International journal of hematology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE) is a leading cause of maternal mortality. Few studies have evaluated the individual risk of gestational VTE associated with heritable thrombophilia, and current recommendations for antenatal thromboprophylaxis in women with severe thrombophilia such as homozygous factor V Leiden mutation (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.